Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

Barbara Pro, Ranjana Advani, Pauline Brice, Nancy L Bartlett, Joseph D. Rosenblatt, Timothy Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle Fanale, Joseph M. Connors, Keenan Fenton, Dirk Huebner, Juan Pinelli, Dana A Kennedy, Andrei Shustov

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology

Neuroscience